Inventaire - your friends and communities are your best library - Inventaire

Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials

published in: Clinical Rehabilitation

date of publication: 2009-04-23

main subject: systematic review, cerebral palsy, botulinum toxin type A, spasticity

Cites articles 24

Date

Title

Authors

2008-01-01

Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial.

Rory Wolfe, John B. Carlin
2007-12-01

Pharmacology of therapeutic botulinum toxin preparations
2007-07-01

Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-A injections in children with spastic hemiplegia.

Jacques Duysens
2007-05-01

A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity.
2007-07-01

Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation
2007-03-01

An agenda for future debate on concepts of health and disease.
2006-02-01

Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc
2006-10-01

Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review

Eun Sook Park, Dong-wook Rha
2006-06-01

AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections.

Natasha A. Lannin
2006-12-01

Safety and efficacy of botulinum toxin type A following long-term use

Alberto Albanese
2006-07-01

Comparison of the efficacies of botulinum toxin A and Johnstone pressure splints against hip adductor spasticity among patients with cerebral palsy: a randomized trial.
2005-12-19

Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study

Rudolf Korinthenberg, Steffen Berweck, Florian Heinen
2005-09-01

Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases
2004-02-01

Neurobiological basis for the use of botulinum toxin in pain therapy
2004-07-01

Safety of botulinum toxin type A: a systematic review and meta-analysis

Joseph Jankovic
2004-11-01

Better reporting of harms in randomized trials: an extension of the CONSORT statement

Peter C. Gøtzsche, John Ioannidis, Douglas G. Altman, David Moher, Kenneth F Schulz
2004-05-01

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

Michael J Sweeting, Paul C Lambert
2004-07-01

Detection, verification, and quantification of adverse drug reactions

Bruce M. Psaty
2001-11-01

Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review
2001-11-01

Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
2001-11-01

The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial.
2000-12-01

Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy

Victoria Allgar
1999-10-01

Explaining heterogeneity in meta-analysis: a comparison of methods.
1986-09

Meta-analysis in clinical trials

Nan Laird, Rebecca DerSimonian

Article - wd:Q37457570

Welcome to Inventaire

the library of your friends and communities

you are offline